The U.S. Supreme Court has overturned rulings made by three California courts that concluded they had specific jurisdiction over lawsuits brought by out-of-state residents against a company not incorporated or headquartered there. And reverberations from the decision will likely be felt in Cook County courtrooms, say observers.
Label or Liability: Case law could lead to short shelf life for $3M Paxil 'innovator liability' verdict
A Chicago federal jury shocked many observers by ordering drugmaker GlaxoSmithKline to pay $3 million to the widow of lawyer Stewart Dolin, who committed suicide in 2010 after taking a generic version of GSK's antidepressant Paxil. But legal observers believe the decision may have a short shelf life, as it could defy decades of case law on the concept of innovator liability.
Drug manufacturer GlaxoSmithKline is trying to get out from under a $3 million jury judgment, which blamed it for a Chicago lawyer’s suicide, saying a federal judge made multiple mistakes that hamstrung the manufacturer’s defense against the claim its labels failed to warn its anti-depressant drug Paxil and its generic equivalent can lead to suicide.
Consumers too far down distribution chain to press price fixing class action vs steelmakers, says judge
A group of steel makers, led by Chicago-based ArcelorMittal USA, have beaten down a class-action antitrust lawsuit filed by more than a dozen consumers, who alleged the companies schemed to raise prices for goods made with steel, by pointing out the consumers were too far down the distribution line from the steel manufacturers to claim losses.
This week, a Chicago federal court will empanel jurors to decide whether pharmaceutical maker GlaxoSmithKline should be made to pay the widow of a Chicago lawyer who committed suicide by jumping in front of a train after taking a generic version of Paxil, an antidepressant developed by GSK, because, the woman claims, the drug’s warning label, which was approved by federal regulators, did not contain enough information on suicide risk, misleading the doctor who prescribed it.
Chicago Bears legend Brian Urlacher – a player whose exceptional, bruising play on the field was accentuated by his clean shaven head – has rushed to sack a Florida medical practice the middle linebacker said has wrongly profited from baldly using Urlacher’s name and hair regrowth success to market his services.
Volvo's offer to refund purchase price of 'underperforming' hybrid SUV nixed class action vs automaker
Volvo will not have to face a class action complaint about its hybrid vehicles after a federal judge in Chicago agreed to dismiss a lawsuit which demanded Volvo refund tens of thousands of dollars to everyone who purchased one of the automaker’s hybrid SUVs, which plaintiffs alleged underperformed its advertised battery-only driving range.
A federal judge has tossed out a racial discrimination lawsuit brought by the African-American owners of a garbage hauling company, who had alleged Chicago city officials and representatives of two other waste haulers had conspired to lock their smaller, minority-owned rival out of the city’s waste hauling business, saying the small business owners had not offered nearly enough evidence to back their assertions.
The Illinois First District Appellate Court has upheld a Cook County Circuit Court ruling that an increase in the state’s cigarette tax does not violate the state constitution. Casey’s Marketing Company, which operates hundreds of Casey’s General Store convenience stores, filed the initial complaint in the wake of state legislation in 2012 to roughly double the per cigarette tax charged to those who sell them.
A group of more than two dozen California wineries who ship wine to Illinois customers have scored a legal win, as a Cook County judge granted the request of Illinois Attorney Gen. Lisa Madigan to dismiss numerous lawsuits alleging the wineries had shorted the state's treasury by not paying sales taxes on shipping and handling fees they charged consumers.
A federal judge has tossed, with leave to amend, the bulk of a federal racketeering and fraud class action brought by an Ohio-based health insurer against Abbvie and other makers of testosterone drugs, saying the insurer has not yet backed up with enough particularity its allegations the drugmakers invented the condition known as “low T,” and, through false marketing to doctors, patients and insurers alike, induced insurers and others to pay far more for the drugs to treat the condition.